Feed-Forward Deep Neural Networks Predict Substrate-Specific Effects of Transporter Variants to Explain Drug Response Variability.

Yoomi Park, Yitian Zhou, Ming Xiao, Anne T Nies, Volker M Lauschke

Journal: Clinical and translational science 2026;19(5):e70592

PMID: 42104208

Abstract

Genetic variants in drug transporter genes shape the interindividual variability in drug response. However, their functional interpretation has remained limited due to the substrate dependence of variant effects. Existing predictors are substrate-agnostic and cannot capture how a single amino acid change differentially affects transport across drugs. Here, we present the substrate-specific effect predictor (SSEP), the first model to predict transporter variant effects in a substrate-dependent manner. SSEP integrates curated in vitro uptake assays with deep mutational scanning data, leveraging multiscale features extracted from modeled variant-substrate complexes. Based on a feed-forward deep neural network architecture, SSEP provides quantitative, substrate-specific activity scores that correlate with experimental uptake data (Spearman's ρ = 0.64) across multiple transporter families (OCT1, MATE, CNT, and OATP) and substrate classes (biguanides, tetraethylammonium, selective serotonin agonists, sympathomimetics and opiates). In benchmarking analyses, SSEP showed higher concordance (Kruskal-Wallis p = 1.11 × 10-41) with experimental uptake than commonly used substrate-agnostic predictors. Application of SSEP on UK Biobank data revealed that OCT1 (SLC22A1) variant burden weighted by metformin-specific SSEP scores was significantly associated with maintenance dose (β = 30 mg/day per unit increase in predicted functional burden; p = 0.033), whereas substrate-agnostic weights showed no association (p = 0.78). Together, these results show that SSEP enables quantitative, drug-specific prediction of transporter variant effects, thereby improving the identification of clinically relevant transporter variants in population-scale data.

© 2026 The Author(s). Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.

Address: Department of Physiology and Pharmacology and Center for Molecular Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden.; Medical Research Center, Seoul National University College of Medicine, Seoul, South Korea.; Department of Physiology and Pharmacology and Center for Molecular Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden.; Department of Information Science and Engineering, Royal Institute of Technology, KTH, Stockholm, Sweden.; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tübingen, Tübingen, Germany.; Department of Physiology and Pharmacology and Center for Molecular Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden.; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tübingen, Tübingen, Germany.; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.